The Emperor of All Maladies — A Biography of Cancer

Siddhartha Mukherjee trained as an oncologist and won a Pulitzer Prize for writing. The Emperor of All Maladies deploys both skill sets in a work of genuine magnitude: a four-thousand-year history of humanity’s encounter with cancer, told through the stories of the patients, physicians, and scientists who defined that encounter. The title comes from a description of cancer by a fourteenth-century Persian physician, and it captures what the disease has been for most of human history: not just incurable but incomprehensible, appearing from nowhere, consuming the body from within, defeating every treatment with what seems like malevolent intelligence. Mukherjee’s project is to trace how that incomprehension was slowly, painfully, and incompletely replaced by understanding.

The book’s historical sweep is astonishing. Mukherjee traces cancer treatment from Edwin Smith’s ancient Egyptian papyrus describing surgical excision through the brutal radical mastectomies of William Halsted in the late nineteenth century — which removed not just the breast but the chest wall and lymph nodes, on the basis of a theory of local spread that was wrong — through the development of chemotherapy from mustard gas research after World War II, the radiation revolution, and the emergence of targeted molecular therapy in the 1990s. Each era’s treatment reflects the understanding of its time, and the errors of each era are as instructive as the successes. When the biological model is wrong, the treatment will be wrong, and patients suffered horrifically for decades on the basis of incorrect theories held with absolute confidence.

The scientific climax is the understanding of cancer as a genetic disease — specifically, a disease of the genome’s own regulatory machinery gone wrong. Oncogenes (genes that, when mutated, drive abnormal cell division) and tumour suppressor genes (genes that, when silenced, fail to brake that division) are the fundamental actors. This understanding, achieved through decades of molecular biology from the 1970s onward, enabled the first genuinely targeted therapies: drugs designed to block the specific molecular aberrations driving specific cancers rather than simply killing all rapidly dividing cells. Gleevec, the first major success of this approach for chronic myelogenous leukaemia, is one of the book’s climactic moments.

Throughout the history, Mukherjee weaves the stories of his own patients — particularly a young woman named Carla, diagnosed with acute lymphocytic leukaemia, whose treatment and uncertain survival he describes with tender clinical precision. These personal threads transform what could be a dry institutional history into something deeply human. At nearly 600 pages, The Emperor of All Maladies requires serious commitment, but it repays it fully. It is one of the great works of narrative medicine, a book that will permanently change how you understand cancer and how you understand the enterprise of science itself.